Quanterix’s (NASDAQ:QTRX) quiet period will end on Tuesday, January 16th. Quanterix had issued 4,275,200 shares in its public offering on December 7th. The total size of the offering was $64,128,000 based on an initial share price of $15.00. During the company’s quiet period, insiders and underwriters that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Several equities research analysts recently weighed in on QTRX shares. BTIG Research started coverage on shares of Quanterix in a report on Tuesday, January 2nd. They issued a “buy” rating and a $26.00 price objective for the company. Leerink Swann started coverage on shares of Quanterix in a research report on Tuesday, January 2nd. They issued an “outperform” rating and a $27.00 price target on the stock. Cowen started coverage on shares of Quanterix in a research report on Tuesday, January 2nd. They issued an “outperform” rating on the stock. Finally, JPMorgan Chase & Co. started coverage on shares of Quanterix in a research report on Tuesday, January 2nd. They issued an “overweight” rating on the stock.

Shares of Quanterix (QTRX) opened at $20.07 on Thursday. Quanterix has a 1 year low of $15.56 and a 1 year high of $23.70. The company has a market cap of $399.83 and a PE ratio of -12.95.

In other Quanterix news, Director David R. Walt purchased 200,000 shares of the company’s stock in a transaction on Monday, December 11th. The shares were purchased at an average cost of $15.00 per share, for a total transaction of $3,000,000.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Venture Fund Viii Overage Arch purchased 266,000 shares of the company’s stock in a transaction on Monday, December 11th. The stock was acquired at an average price of $15.00 per share, for a total transaction of $3,990,000.00. The disclosure for this purchase can be found here. Over the last quarter, insiders acquired 500,000 shares of company stock worth $7,500,000.

TRADEMARK VIOLATION NOTICE: “Quanterix Corp’s Quiet Period Set To Expire on January 16th (NASDAQ:QTRX)” was reported by Watch List News and is the property of of Watch List News. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/quanterix-corps-quiet-period-set-to-expire-on-january-16th-nasdaqqtrx/1802075.html.

About Quanterix

Quanterix Corporation is a United States-based company, which is a developer of tools in high definition diagnostics. The Company offers single molecule array (Simoa) platform, whcich uses single molecule measurements to access proteins. Simoa focuses on research and clinical testing applications. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology.

Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with Analyst Ratings Network's FREE daily email newsletter.